Trending Now
Free Weekly Newsletter.
We've been publishing our newsletter since 1998, and have had our share of huge winners including Immunomedics (IMMU) $3.00 to $86.00 (2016-2020). So sign up, it's free, and see what else we can come up with!
ALL NEWS
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of John's accolades, but this is more than enough for us....
Three Stocks Percolating, Up 106%, Up 169%, and up 483%.
Odyssey Marine (OMEX) gained 169%, on a 259 million share day, from where we added it to 2026 Watch list. Society Pass (SOPA) gained 106%, from its recent low on a 55 million share...
11 Publicly Traded Companies Cashing in on the AI Cyber Threat Boom
Why the Cybersecurity Sector Is Poised for Explosive Growth Over the Next Five Years
Awareness of the Dangers Is Exploding Upward — and With It, Cybersecurity Budgets
For the first time in history, cybercrime is being...
From $0 to a $1 Billion Valuation in 6 Years, via eSims.
How To Build A Unicorn with Ahmet Bahadir Ozdemir (Airalo) | Antler Global
Fantastic "accidental telecom guy" who turned Sim4Crew which started out as SIM cards for crew members and sailors on ships, into a...
Odyssey Marine (OMEX) Gains 169% on Merger News
American Ocean Minerals Corporation to Merge with Odyssey Marine Exploration, Inc., Creating a $1B U.S.-Controlled Deep-Sea Critical Minerals Platform
March 30th: Adding Odyssey Marine (OMEX) $0.79 and Advanced Gold Exploration $0.36 to Precious Metals Watch...
TMC Pushes US Seafloor Mining Hub.
With 413 million shares outstanding, TMC has lost $2.9 billion in market value in the most recent rout!
Investors have to keep reminding themselves that a pre-feasibility study issued earlier this year assigned a net...
Palantir’s Billionaire CEO, “People With ADHD Will Succeed in the AI Era.”
“There are basically two ways to know you have a future,” the 58-year-old billionaire Alex Karp said on TBPN earlier this month. “One, you have some vocational training. Or two, you’re neurodivergent.” More broadly, neurodivergence can include conditions such...
Trader in Iran Made Nearly $1 Million on Polymarket With Remarkably Accurate War Bets!
This is fun reading..from CNN
Full Article on CNN
Institutional Gold Analyst: 2026 Watch List.
The Perfect Timing - for Precious Metals..
Timing is a 'personal' issue, related to short and long-term investor goals, but generally speaking (for long-term investors), the timing right now to build a precious metals model...
The Iran War and AI Cyber Threats
Virtually all cyberattacks will be AI-enabled or entirely AI, says Armadin CEO Kevin Mandia
Kevin Mandia, Armadin CEO, joins ‘Squawk Box’ to discuss the cyber threats facing the U.S. amid the Iran war, impact of...
National Investment Bankers Conference Cheat Sheet
Companies Scheduled to Present
Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. They have hosted 150 investment conferences showcasing public and private companies seeking access to...
Report: Sekur Private Data (SWISF) Awarded Place on GSA Schedule.
This Week's GSA Announcement Marks Sekur’s 4th Major Milestone.
GSA Approval is akin to an electrician just starting out in the business, and being told by a friend "I know a guy, my cousin, who...
Sekur Private Data (SWISF) Locked and Loaded.
We Can Feel the Wind Behind Its Back!
Sekur (SWISF) probably has one of the simplest stories we follow. Risky because it is a modestly financed start-up. Today they announced a progress report for shareholders...
Gold, Silver & Critical Minerals. 2025 Watch List Update.
Like with Most in Precious Metals, Our Ideas are Performing Rather Well.
And we have a new name! Adding Americore Resources (AMCOF) $0.54, to the 2026 Watch List.
We got bullish on Gold back...
News Update on Society Pass (SOPA) $0.64.
Society Pass (SOPA) $0.64, Announces $3.0 Million Public Offering; Share Count Increases to Approximately 13.0 Million.
Review of four Research Reports with Price Targets Exceeding $10 Per Share
Click to review the report.
Society Pass Incorporated (“Society...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of John's accolades, but this is more than enough for us....
11 Publicly Traded Companies Cashing in on the AI Cyber Threat Boom
Why the Cybersecurity Sector Is Poised for Explosive Growth Over the Next Five Years
Awareness of the Dangers Is Exploding Upward — and With It, Cybersecurity Budgets
For the first time in history, cybercrime is being...
The Iran War and AI Cyber Threats
Virtually all cyberattacks will be AI-enabled or entirely AI, says Armadin CEO Kevin Mandia
Kevin Mandia, Armadin CEO, joins ‘Squawk Box’ to discuss the cyber threats facing the U.S. amid the Iran war, impact of...
Sekur Private Data (SWISF) Locked and Loaded.
We Can Feel the Wind Behind Its Back!
Sekur (SWISF) probably has one of the simplest stories we follow. Risky because it is a modestly financed start-up. Today they announced a progress report for shareholders...
News Update on Society Pass (SOPA) $0.64.
Society Pass (SOPA) $0.64, Announces $3.0 Million Public Offering; Share Count Increases to Approximately 13.0 Million.
Review of four Research Reports with Price Targets Exceeding $10 Per Share
Click to review the report.
Society Pass Incorporated (“Society...
$269 Million in Cash. $178 Million Market Cap. What are the Odds? Adding to...
Here's the balance sheet.. Imagine being the CEO?
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but...
GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
Adding Oncolytics Biotech Inc. (ONCY) $1.02 to 2025 Watch List.
The Oncolytics Biotech Inc. (ONCY) idea is coming from one of our top 'tipsters' the Big Wig - whose two previous ideas, Allarity (ALLR)...
IPOS
The Resurgence Of Selling Shareholders In Microcap IPOs
Forbes Finance Council
In today’s capital markets landscape, the initial public offering market is experiencing significant challenges, especially for microcap companies seeking to meet certain...
conference calls
Hidden Gem and a Monster in the Making? Beasley Broadcast Group...
If They Simply Changed Their Name to Beasley Internet Group, it Could be Revalued 3-Fold Higher.
We attended their Investor Dinner in Boca Raton...
Most popular
Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...
Topline Results anticipated by the end of Q2 2023
CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced...
United States Antimony (UAMY) on Fox News.
DALLAS, TX / ACCESS Newswire / June 4, 2025 / United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE American: UAMY), announced today that its Chairman...
Sekur Private Data (SKUR, SWISF) Announces First Significant Corporate Account.
Receives Proposal Request for First 1,200 Sekur SMB Bundle Licenses.
News today of Sekur's first Corporate Account in the Democratic Republic of the Congo (DRC)....
Two Biotech Stocks on Takeover List?
Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD).
Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand out as potential takeover candidates among biotech...












































